¼¼ºê¶õ½ºº´¿ø ´ëÇѹé¹ÝÁõÇÐȸ Á¦ 10Â÷ ½ÉÆ÷Áö¾ö : 2019-04-06±³À°ÀÏÀÚ : 2019-04-06
±³À°Àå¼Ò : ¼¼ºê¶õ½ºº´¿ø Á¾ÇÕ°ü 3Ãþ 337È£
±³À°ÁÖÁ¦ :
´ëÇѹé¹ÝÁõÇÐȸ Á¦ 10Â÷ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѹé¹ÝÁõÇÐȸ
´ã´çÀÚ : ¿À»óÈ£
¿¬¶ôó : 02-2228-2080
À̸ÞÀÏ :
kda@derma.or.kr ±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í ÇöÀåµî·Ï¸¸ °¡´É: ÇǺΰúÀü¹®ÀÇ 2¸¸¿ø, ÇǺΰúÀü°øÀÇ 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-06 337È£ 13:10~13:30 Interplay between oxidative stress and immune system ¿À»óÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-06 337È£ 13:30~13:50 A symphony of various kinds of immune cells responsible for vitiligo ÀÌ»óÈÆ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04-06 337È£ 13:50~14:10 Melanocyte stem cells and paracrine factors for melanocyte regeneration in vitiligo °Èñ¿µ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 04-06 337È£ 14:10~14:30 Pratical tips for the treatment of segmental vitiligo À̵¿À±(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-06 337È£ 14:30~14:50 Protocols of phototherapy in vitiligo treatment ½ÅÁ¤Çö(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 04-06 337È£ 14:50~15:10 The bottomline of surgical treatments of vitiligo ¹ÚÁöÈÆ(¿ìÅÂÇÏÇѽ°æÇǺΰú)
ÈÞ½Ä 04-06 337È£ 15:10~15:40 coffee break ()
±³À°½Ã°£ 04-06 337È£ 15:40~16:10 FoxP3 regulatory T cells in immune-mediated tissue injury ÃÖÀ±¼®(Ãæ³²ÀÇ´ë Ç÷¾×³»°ú)
±³À°½Ã°£ 04-06 337È£ 16:10~16:30 Introduction of recent clinical trials and upcoming targeted medical therapy ¹èÁ¤¹Î(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-06 337È£ 16:30~16:50 Immune checkpoint blockers and vitiligo ÃÖÁ¾¿ø(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04-06 337È£ 16:50~17:10 Comorbidities of vitiligo and laboratory tests for evaluation of comorbidities ÀÌÈñÁ¤(Â÷ÀÇ°ú´ë)
±³À°½Ã°£ 04-06 337È£ 17:10~18:00 Development of vitiligo after immunotherapy for breast cancer ±èÁ¦¹Î(¿¬¼¼ÀÇ´ë)